Croda International (LON:CRDA) Given Buy Rating at Jefferies Financial Group

Key Points

• Jefferies Financial Group has reaffirmed a buy rating for Croda International, setting a price target of GBX 3,200, which suggests a potential upside of 16.15% from its previous close.
• Other analysts have mixed ratings on the stock, with Deutsche Bank lowering their target to GBX 3,000 while Berenberg maintains a buy rating at GBX 3,100, giving Croda an average rating of Moderate Buy.
• In recent insider transactions, Chris Good and Stephen Oxley acquired shares at around GBX 2,633 and GBX 2,671 per share, respectively, suggesting confidence from management in the stock’s future performance.

Croda International (LON:CRDA - Get Free Report)'s stock had its "buy" rating reaffirmed by stock analysts at Jefferies Financial Group in a research report issued on Wednesday,Digital Look reports. They currently have a GBX 3,200 price target on the stock. Jefferies Financial Group's target price would indicate a potential upside of 16.15% from the company's previous close.

Other analysts have also issued research reports about the stock. Deutsche Bank Aktiengesellschaft dropped their target price on shares of Croda International from GBX 3,400 to GBX 3,000 and set a "hold" rating on the stock in a research report on Tuesday, July 29th. Berenberg Bank lowered their target price on shares of Croda International from GBX 3,800 to GBX 3,100 and set a "buy" rating on the stock in a research note on Tuesday, July 29th. Finally, JPMorgan Chase & Co. raised Croda International to an "overweight" rating in a report on Wednesday, July 30th. Three research analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to MarketBeat, the company has an average rating of "Moderate Buy" and a consensus price target of GBX 3,150.

Croda International Price Performance

LON:CRDA opened at GBX 2,755 on Wednesday. The company has a quick ratio of 2.25, a current ratio of 2.72 and a debt-to-equity ratio of 30.90. Croda International has a 52 week low of GBX 2,426.77 and a 52 week high of GBX 4,325. The stock's 50-day moving average price is GBX 2,588.44 and its 200-day moving average price is GBX 2,830.45. The stock has a market capitalization of £3.85 billion, a PE ratio of 1,788.96, a price-to-earnings-growth ratio of 1.40 and a beta of 0.74.

Croda International (LON:CRDA - Get Free Report) last issued its quarterly earnings results on Tuesday, July 29th. The company reported GBX 72.20 earnings per share (EPS) for the quarter. Croda International had a return on equity of 6.96% and a net margin of 9.98%. As a group, equities analysts expect that Croda International will post 181.8307268 EPS for the current fiscal year.

Insider Transactions at Croda International

In related news, insider Chris Good acquired 1,000 shares of the business's stock in a transaction dated Wednesday, August 6th. The shares were acquired at an average price of GBX 2,633 per share, with a total value of £26,330. Also, insider Stephen Oxley acquired 3,762 shares of Croda International stock in a transaction dated Tuesday, July 29th. The stock was bought at an average price of GBX 2,671 per share, for a total transaction of £100,483.02. In the last ninety days, insiders have acquired 11,343 shares of company stock valued at $29,823,659. 0.83% of the stock is owned by corporate insiders.

Croda International Company Profile

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.